Neuro-Oncology is delighted to report that our 2011 Impact Factor is 5.723, a notable increase from last year's 5.483.
The Impact Factor, a metric used to assess journal quality, is calculated by dividing the number of articles published in the previous 2 years into the number of citations of those articles in the reported year (i.e., the The journal is now ranked 15th of 191 clinical neurology journals (top 8%) and 22nd of 194 oncology journals (top 11%); both of these rankings are higher than last year's. Neuro-Oncology increased its publication frequency from quarterly to bimonthly in 2008 and to monthly in 2010, so we are excited to see that our rapid growth has been accompanied by sustained (and even increased) quality. Additional changes, such as requiring structured abstracts in 2012 and cell line validation statements in 2013, should further improve the journal's quality.
We thank all of you-our authors, reviewers, editors, and readers-for your contributions during the past year; we look forward to working with you to ensure that Neuro-Oncology remains the top journal in its field.
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